NRx Pharmaceuticals, Inc. (NRXP) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

NRx Pharmaceuticals, Inc. (NRXP) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

NRXP Income Statement

NRx Pharmaceuticals, Inc. (NRXP) annual income statement — 9-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	1.1M	1.07M	983K	242K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	843K	796K	508K	138K	0	0	1K	2K	1K	1K	1K	2K	1K	1K	1K	1K	1K	1K	395	638
COGS % of Revenue	76.57%	74.53%	51.68%	57.02%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	258K	272K	475K	104K	0	0	-1K	-2K	-1K	-1K	-1K	-2K	-1K	-1K	-1K	-1K	-1K	-1K	-395	-638
Gross Margin %	23.43%	25.47%	48.32%	42.98%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	47600%	5300%	100%	100%	0%	0%	0%	0%	0%	-100%	0%	0%	-153.16%	-56.74%	-3.41%	-	55.62%	-
Operating Expenses	6.76M	5.02M	5.07M	4.22M	3.73M	3.85M	3.63M	3.02M	7.05M	6M	4.41M	5.81M	7.94M	9.43M	9.89M	9.14M	9.6M	15.7M	52.97M	20.1M
OpEx % of Revenue	614.26%	470.04%	515.67%	1744.63%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	4.75M	3.71M	4.51M	2.79M	2.74M	2.94M	2.6M	2.41M	4.25M	4.25M	1.87M	2.49M	4.06M	5.78M	5.43M	5.01M	6.64M	10.22M	46.56M	13.82M
SG&A % of Revenue	430.97%	347.47%	458.9%	1154.13%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	2.12M	1.31M	558K	1.43M	987K	804K	1.04M	611K	2.8M	1.75M	2.53M	3.31M	3.87M	3.65M	4.46M	4.13M	2.96M	5.48M	6.41M	6.28M
R&D % of Revenue	192.19%	122.57%	56.77%	590.5%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-98K	0	0	0	0	100K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-6.5M	-4.75M	-4.59M	-4.12M	-3.73M	-3.85M	-3.63M	-3.02M	-7.05M	-6M	-4.41M	-5.81M	-7.94M	-9.44M	-9.89M	-9.14M	-9.6M	-15.71M	-52.97M	-20.1M
Operating Margin %	-590.83%	-444.57%	-467.34%	-1701.65%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-74.4%	-23.42%	-26.42%	-36.27%	47.09%	35.86%	17.52%	47.97%	11.19%	36.43%	55.44%	36.46%	17.31%	39.92%	81.33%	54.52%	43.91%	-213.47%	-388.72%	-148.59%
EBITDA	-6.44M	-4.58M	-4.49M	-4.08M	-17.58M	-3.85M	-3.63M	-3.02M	-7.05M	-6M	-4.41M	-5.81M	-7.94M	-9.43M	-9.89M	-9.14M	-9.6M	-15.7M	-52.97M	-20.1M
EBITDA Margin %	-584.83%	-429.12%	-457.17%	-1684.71%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	63.38%	-19.16%	-23.7%	-35%	-149.41%	35.87%	17.53%	47.98%	11.19%	36.43%	55.45%	36.48%	17.31%	39.93%	81.34%	54.52%	43.92%	38.38%	-388.76%	-290.32%
D&A (Non-Cash Add-back)	66K	165K	100K	41K	0	1K	1K	2K	1K	1K	1K	2K	1K	1K	1K	1K	1K	1K	395	638
EBIT	-16.28M	-1.2M	1.03M	-5.89M	-17.58M	-5.51M	-9.08M	-1.62M	-7.05M	-6.3M	-4.25M	-6.02M	-8.72M	-11.04M	-10.24M	-9.08M	-6.98M	-13.45M	-30.79M	-37.04M
Net Interest Income	-234K	-228K	-667K	2K	2K	4K	4K	6K	-842K	-203K	-6K	79K	145K	156K	130K	95K	23K	-3K	-2.34K	-5K
Interest Income	6K	5K	4K	2K	2K	4K	4K	6K	7K	27K	74K	119K	145K	156K	130K	95K	23K	0	0	368
Interest Expense	240K	233K	671K	0	0	0	0	0	849K	230K	80K	40K	0	0	0	0	0	3K	2.34K	5.37K
Other Income/Expense	-10.02M	3.32M	4.95M	-1.77M	-13.85M	-1.67M	-5.44M	1.4M	-847K	-530K	74K	-254K	-779K	-1.6M	-353K	58K	2.62M	2.26M	22.18M	-16.95M
Pretax Income	-16.52M	-1.43M	360K	-5.89M	-17.58M	-5.51M	-9.08M	-1.62M	-7.9M	-6.53M	-4.33M	-6.06M	-8.72M	-11.04M	-10.24M	-9.08M	-6.98M	-13.45M	-30.79M	-37.05M
Pretax Margin %	-1500.45%	-133.9%	36.62%	-2433.88%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-16.52M	-1.43M	360K	-5.89M	-17.58M	-5.51M	-9.08M	-1.62M	-7.9M	-6.53M	-4.33M	-6.06M	-8.72M	-11.04M	-10.24M	-9.08M	-6.98M	-13.45M	-30.79M	-37.05M
Net Margin %	-1500.45%	-133.9%	36.62%	-2433.88%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	6.03%	74.06%	103.97%	-262.91%	-122.63%	15.56%	-109.56%	73.23%	9.41%	40.86%	57.7%	33.26%	-24.85%	17.91%	66.74%	75.48%	-5836.42%	47.24%	31.76%	-617.77%
Net Income (Continuing)	-16.52M	-1.43M	360K	-5.89M	-17.58M	-5.51M	-9.08M	-1.62M	-7.9M	-6.53M	-4.33M	-6.06M	-8.72M	-11.04M	-10.24M	-9.08M	-6.98M	-13.45M	-30.79M	-37.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.44	-0.04	0.01	-0.27	-0.98	-0.34	-0.86	-0.15	-0.75	-0.74	-0.05	-0.74	-0.12	-0.19	-0.09	-0.14	-0.07	-2.10	-0.60	-0.38
EPS Growth %	55.1%	87%	101.31%	-80%	-30.67%	54.05%	-1566.67%	79.73%	-525%	-289.47%	40.07%	-428.57%	-80.72%	90.95%	85.65%	63.16%	99.9%	70.42%	96.41%	-171.43%
EPS (Basic)	-0.44	-0.04	0.01	-0.27	-0.98	-0.34	-0.86	-0.15	-0.75	-0.74	-0.05	-0.74	-0.12	-0.19	-0.09	-0.14	-0.07	-0.18	-0.60	-0.38
Diluted Shares Outstanding	37.65M	32.33M	31.73M	22.23M	17.93M	16.41M	10.52M	10.97M	10.52M	8.85M	83.92M	8.2M	73.22M	67.45M	66.45M	66.45M	65.73M	63.67M	51.74M	54.81M
Basic Shares Outstanding	37.65M	32.33M	31.73M	22.23M	17.93M	16.41M	10.52M	10.97M	10.52M	8.85M	83.92M	8.2M	73.22M	67.45M	66.45M	64.88M	65.73M	63.67M	51.74M	54.81M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-